{"id":137829,"date":"2022-04-07T16:28:10","date_gmt":"2022-04-07T21:28:10","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/04\/omicron-ba-2-subvariant-becomes-dominant-in-tokyo"},"modified":"2022-04-07T16:28:10","modified_gmt":"2022-04-07T21:28:10","slug":"omicron-ba-2-subvariant-becomes-dominant-in-tokyo","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/04\/omicron-ba-2-subvariant-becomes-dominant-in-tokyo","title":{"rendered":"Omicron BA.2 subvariant becomes dominant in Tokyo"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/omicron-ba-2-subvariant-becomes-dominant-in-tokyo2.jpg\"><\/a><\/p>\n<p>Officials in Tokyo are concerned about the more transmissible BA.2 Omicron coronavirus subvariant, which is increasingly dominant among infections.<\/p>\n<p>The capital\u2019s expert panel says its screening indicates the BA.2 subvariant accounted for nearly 68 percent of new cases in the week through March 28. The rate has climbed nearly 30 points in the past two weeks.<\/p>\n<p>Tohoku Medical and Pharmaceutical University Professor Kaku Mitsuo said, \u201cWe are at a critical moment where infections will rapidly spread or not.\u201d He added, \u201cWe have to take measures to prevent it from happening.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Officials in Tokyo are concerned about the more transmissible BA.2 Omicron coronavirus subvariant, which is increasingly dominant among infections. The capital\u2019s expert panel says its screening indicates the BA.2 subvariant accounted for nearly 68 percent of new cases in the week through March 28. The rate has climbed nearly 30 points in the past two [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-137829","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/137829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=137829"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/137829\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=137829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=137829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=137829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}